Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-27 Sale |
2025-01-29 5:25 pm |
NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer |
61,883 | $0 | $0 | 1,578,528 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 4:02 pm |
TCR2 THERAPEUTICS INC. | TCRR | Somaiya Mayur Ian Chief Financial Officer |
2,000 | $35 | $70,000 | 104,031 (Direct) |
View |
| 2020-11-17 Sale |
2020-11-19 5:00 pm |
TCR2 THERAPEUTICS INC. | TCRR | Somaiya Mayur Ian Chief Financial Officer |
3,666 | $30 | $109,980 | 106,031 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-27 Exercise |
2025-01-29 5:25 pm |
N/A 2033-11-01 |
NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer |
61,883 | $0 | 1,578,528 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 5:25 pm |
N/A N/A |
NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer |
61,883 | $9.26 | 1,578,528 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-07 5:08 pm |
N/A N/A |
NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer |
38,000 | $0 | 38,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:53 pm |
N/A 2035-01-02 |
NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer |
220,000 | $0 | 220,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:10 pm |
N/A 2034-01-01 |
NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2023-12-29 4:30 pm |
N/A 2033-11-01 |
NewAmsterdam Pharma Co N.V. | NAMS | Somaiya Mayur Ian Chief Financial Officer |
0 | $0 | 824,697 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:02 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | Somaiya Mayur Ian Chief Financial Officer |
2,000 | $5.88 | 104,031 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:02 pm |
N/A 2028-04-29 |
TCR2 THERAPEUTICS INC. | TCRR | Somaiya Mayur Ian Chief Financial Officer |
2,000 | $0 | 104,031 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-11 06:20 am |
N/A 2030-12-09 |
TCR2 THERAPEUTICS INC. | TCRR | Somaiya Mayur Ian Chief Financial Officer |
92,000 | $0 | 93,473 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 5:00 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | Somaiya Mayur Ian Chief Financial Officer |
2,000 | $5.88 | 106,031 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 5:00 pm |
N/A 2028-04-29 |
TCR2 THERAPEUTICS INC. | TCRR | Somaiya Mayur Ian Chief Financial Officer |
2,000 | $0 | 106,031 (Direct) |
View |